Patents by Inventor Glenn Verstraete

Glenn Verstraete has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral dosage form
    Patent number: 11786476
    Abstract: The present invention in general relates to a pharmaceutical dosage form comprising one or more granules, and a method for manufacturing thereof. The granules of the dosage form are prepared via the extrusion/spheronization technique using partially hydrolysed polyvinyl alcohol. These granules have the advantage that a high drug load can be contained therein.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: October 17, 2023
    Assignee: Universiteit Gent
    Inventors: Chris Vervaet, Jean Paul Remon, Glenn Verstraete
  • ORAL DOSAGE FORM
    Publication number: 20210353548
    Abstract: The present invention in general relates to a pharmaceutical dosage form comprising one or more granules, and a method for manufacturing thereof. The granules of the dosage form are prepared via the extrusion/spheronization technique using partially hydrolysed polyvinyl alcohol. These granules have the advantage that a high drug load can be contained therein.
    Type: Application
    Filed: June 11, 2021
    Publication date: November 18, 2021
    Applicant: Universiteit Gent
    Inventors: Chris Vervaet, Jean Paul Remon, Glenn Verstraete
  • Oral dosage form
    Patent number: 11065207
    Abstract: The present invention in general relates to a pharmaceutical dosage form comprising one or more granules, and a method for manufacturing thereof. The granules of the dosage form are prepared via the extrusion/spheronization technique using partially hydrolysed polyvinyl alcohol. These granules have the advantage that a high drug load can be contained therein.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: July 20, 2021
    Assignee: Universiteit Gent
    Inventors: Chris Vervaet, Jean Paul Remon, Glenn Verstraete
  • Oral dosage form
    Patent number: 10966928
    Abstract: The present invention in general relates to a pharmaceutical dosage form comprising one or more granules, and a method for manufacturing thereof. The granules of the dosage form are prepared via the extrusion/spheronization technique using partially hydrolysed polyvinyl alcohol. These granules have the advantage that a high drug load can be contained therein.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: April 6, 2021
    Assignee: Universiteit Gent
    Inventors: Chris Vervaet, Jean Paul Remon, Glenn Verstraete
  • ORAL DOSAGE FORM
    Publication number: 20200297647
    Abstract: The present invention in general relates to a pharmaceutical dosage form comprising one or more granules, and a method for manufacturing thereof. The granules of the dosage form are prepared via the extrusion/spheronization technique using partially hydrolysed polyvinyl alcohol. These granules have the advantage that a high drug load can be contained therein.
    Type: Application
    Filed: March 24, 2017
    Publication date: September 24, 2020
    Applicant: Universiteit Gent
    Inventors: Chris Vervaet, Jean Paul Remon, Glenn Verstraete
  • ORAL DOSAGE FORM
    Publication number: 20200214983
    Abstract: The present invention in general relates to a pharmaceutical dosage form comprising one or more granules, and a method for manufacturing thereof. The granules of the dosage form are prepared via the extrusion/spheronization technique using partially hydrolysed polyvinyl alcohol. These granules have the advantage that a high drug load can be contained therein.
    Type: Application
    Filed: March 13, 2020
    Publication date: July 9, 2020
    Applicant: Universiteit Gent
    Inventors: Chris Vervaet, Jean Paul Remon, Glenn Verstraete